185 related articles for article (PubMed ID: 34786372)
21. Squamous Cell Carcinoma Antigen in Psoriasis: An Immunohistochemical Study.
Ghonemy S; Mohamed B; Elkashishy K; Ibrahim AM
J Clin Aesthet Dermatol; 2021 Sep; 14(9):50-53. PubMed ID: 34980972
[TBL] [Abstract][Full Text] [Related]
22. Immunoinflammatory Biomarkers in Serum Are Associated with Disease Severity in Atopic Dermatitis.
Holm JG; Hurault G; Agner T; Clausen ML; Kezic S; Tanaka RJ; Thomsen SF
Dermatology; 2021; 237(4):513-520. PubMed ID: 33730733
[TBL] [Abstract][Full Text] [Related]
23. Thymus and activation-regulated chemokine in atopic dermatitis: Serum thymus and activation-regulated chemokine level is closely related with disease activity.
Kakinuma T; Nakamura K; Wakugawa M; Mitsui H; Tada Y; Saeki H; Torii H; Asahina A; Onai N; Matsushima K; Tamaki K
J Allergy Clin Immunol; 2001 Mar; 107(3):535-41. PubMed ID: 11240957
[TBL] [Abstract][Full Text] [Related]
24. Gene expression of human squamous cell carcinoma antigens 1 and 2 in human cell lines.
Hamada K; Hanakawa Y; Hashimoto K; Iwamoto M; Kihana T; Hirose S; Nakamura M; Ito M
Oncol Rep; 2001; 8(2):347-54. PubMed ID: 11182054
[TBL] [Abstract][Full Text] [Related]
25. Serum concentration of macrophage-derived chemokine may be a useful inflammatory marker for assessing severity of atopic dermatitis in infants and young children.
Leung TF; Ma KC; Hon KL; Lam CW; Wan H; Li CY; Chan IH
Pediatr Allergy Immunol; 2003 Aug; 14(4):296-301. PubMed ID: 12911508
[TBL] [Abstract][Full Text] [Related]
26. Molecular cloning of human squamous cell carcinoma antigen 1 gene and characterization of its promoter.
Hamada K; Shinomiya H; Asano Y; Kihana T; Iwamoto M; Hanakawa Y; Hashimoto K; Hirose S; Kyo S; Ito M
Biochim Biophys Acta; 2001 Mar; 1518(1-2):124-31. PubMed ID: 11267667
[TBL] [Abstract][Full Text] [Related]
27. Infantile atopic dermatitis: Serum vitamin D, zinc and TARC levels and their relationship with disease phenotype and severity.
Esenboga S; Cetinkaya PG; Sahiner N; Birben E; Soyer O; Sekerel BE; Sahiner UM
Allergol Immunopathol (Madr); 2021; 49(3):162-168. PubMed ID: 33938202
[TBL] [Abstract][Full Text] [Related]
28. Serum Thymus and Activation Regulated Chemokine (TARC), IL- 18 and IL-18 Gene Polymorphism as Associative Factors with Atopic Dermatitis.
Gohar MK; Atta AH; Nasr MM; Hussein DN
Egypt J Immunol; 2017 Jun; 24(2):9-22. PubMed ID: 29528575
[TBL] [Abstract][Full Text] [Related]
29. Serum thymus and activation-regulated chemokine (TARC) and cutaneous T cell- attracting chemokine (CTACK) levels in allergic diseases: TARC and CTACK are disease-specific markers for atopic dermatitis.
Hijnen D; De Bruin-Weller M; Oosting B; Lebre C; De Jong E; Bruijnzeel-Koomen C; Knol E
J Allergy Clin Immunol; 2004 Feb; 113(2):334-40. PubMed ID: 14767451
[TBL] [Abstract][Full Text] [Related]
30. Co-expression of the squamous cell carcinoma antigens 1 and 2 in normal adult human tissues and squamous cell carcinomas.
Cataltepe S; Gornstein ER; Schick C; Kamachi Y; Chatson K; Fries J; Silverman GA; Upton MP
J Histochem Cytochem; 2000 Jan; 48(1):113-22. PubMed ID: 10653592
[TBL] [Abstract][Full Text] [Related]
31. Increased expression level of squamous cell carcinoma antigen 2 and 1 ratio is associated with poor prognosis in early-stage uterine cervical cancer.
Hsu KF; Huang SC; Shiau AL; Cheng YM; Shen MR; Chen YF; Lin CY; Lee BH; Chou CY
Int J Gynecol Cancer; 2007; 17(1):174-81. PubMed ID: 17291250
[TBL] [Abstract][Full Text] [Related]
32. Combination of serum squamous cell carcinoma antigens 1 and 2 as potential diagnostic marker for sinonasal squamous cell carcinoma and inverted papilloma.
Yasumatsu R; Nakano T; Sato M; Jiroumaru R; Hashimoto K; Kogo R; Wakasaki T; Nakashima T; Nakagawa T
Head Neck; 2018 Dec; 40(12):2583-2589. PubMed ID: 30376194
[TBL] [Abstract][Full Text] [Related]
33. Significant elevation of serum levels of eotaxin-3/CCL26, but not of eotaxin-2/CCL24, in patients with atopic dermatitis: serum eotaxin-3/CCL26 levels reflect the disease activity of atopic dermatitis.
Kagami S; Kakinuma T; Saeki H; Tsunemi Y; Fujita H; Nakamura K; Takekoshi T; Kishimoto M; Mitsui H; Torii H; Komine M; Asahina A; Tamaki K
Clin Exp Immunol; 2003 Nov; 134(2):309-13. PubMed ID: 14616792
[TBL] [Abstract][Full Text] [Related]
34. Serum thymus and activation-regulated chemokine, macrophage-derived chemokine and eotaxin as markers of severity of atopic dermatitis.
Jahnz-Rozyk K; Targowski T; Paluchowska E; Owczarek W; Kucharczyk A
Allergy; 2005 May; 60(5):685-8. PubMed ID: 15813816
[TBL] [Abstract][Full Text] [Related]
35. Serum TARC and CTACK concentrations in children with atopic dermatitis, allergic asthma, and urticaria.
Machura E; Rusek-Zychma M; Jachimowicz M; Wrzask M; Mazur B; Kasperska-Zajac A
Pediatr Allergy Immunol; 2012 May; 23(3):278-84. PubMed ID: 22017510
[TBL] [Abstract][Full Text] [Related]
36. Are age-specific high serum IgE levels associated with worse symptomatology in children with atopic dermatitis?
Hon KL; Lam MC; Leung TF; Wong KY; Chow CM; Fok TF; Ng PC
Int J Dermatol; 2007 Dec; 46(12):1258-62. PubMed ID: 18173519
[TBL] [Abstract][Full Text] [Related]
37. Prognostic value of human papillomavirus and squamous cell carcinoma antigen in head and neck squamous cell carcinoma.
Deng Z; Hasegawa M; Yamashita Y; Matayoshi S; Kiyuna A; Agena S; Uehara T; Maeda H; Suzuki M
Cancer Sci; 2012 Dec; 103(12):2127-34. PubMed ID: 22937809
[TBL] [Abstract][Full Text] [Related]
38. Elevation of serum squamous cell carcinoma antigen 2 in patients with psoriasis: associations with disease severity and response to the treatment.
Watanabe Y; Yamaguchi Y; Komitsu N; Ohta S; Azuma Y; Izuhara K; Aihara M
Br J Dermatol; 2016 Jun; 174(6):1327-36. PubMed ID: 26822223
[TBL] [Abstract][Full Text] [Related]
39. Relative levels of SCCA2 and SCCA1 mRNA in primary tumors predicts recurrent disease in squamous cell cancer of the head and neck.
Stenman J; Hedström J; Grénman R; Leivo I; Finne P; Palotie A; Orpana A
Int J Cancer; 2001 Jan; 95(1):39-43. PubMed ID: 11241309
[TBL] [Abstract][Full Text] [Related]
40. The clinical value of serum squamous cell carcinoma antigens 1 and 2 in head and neck squamous cell carcinoma.
Yasumatsu R; Nakano T; Hashimoto K; Kogo R; Wakasaki T; Nakagawa T
Auris Nasus Larynx; 2019 Feb; 46(1):135-140. PubMed ID: 30078551
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
